HSP90AA1 and breast cancer: The plasma concentrations of Hsp90α were noted to be higher in breast cancer patients than the control group [11,15], however there are currently no clinical trials to investigate whether plasma Hsp90α could be applied to the auxiliary diagnosis of breast cancer.